Clinical Trial Update: Effects of Intranasal Administration of Oxytocin in Adults With Prader-Willi Syndrome [Phase 2, Phase 3]

View source ↗

Summary

An update on a Phase 2/3 trial evaluating intranasal oxytocin in adults with Prader-Willi syndrome. The study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prader-willi Syndrome

Drugs mentioned

• Oxytocin (intranasal) (oxytocin)

Snippet

Sponsor: University Hospital, Toulouse | Conditions: Prader-Willi Syndrome | Phase 2, Phase 3 | Status: COMPLETED